Concepedia
Statistics
Publications
16
Citations
2.1K
H-Index
Active since
2002
Affiliations
Universitat de Barcelona(Current)
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
Pfizer (United States)
Marta López‐Parra is an author at Universitat de Barcelona specializing in pharmacology, medicine, and oxidative stress.
Top concepts
MedicinePharmacologyLiver PhysiologyOxidative StressMetabolismBiochemistryInflammationHepatologyCell DeathImmunology
Publications per year
2002–2011
Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins
Ana González‐Périz, Raquel Horrillo, Natàlia Ferré et al. · The FASEB Journal · 2009 · 553 citations · Full text
Insulin Receptor, ω‐3 Fatty Acids, Fatty Liver Disease +20
Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts
Eva Morán‐Salvador, Marta López‐Parra, Verónica García‐Alonso et al. · The FASEB Journal · 2011 · 377 citations
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA
Ana González‐Périz, Anna Planagumà, Karsten Gronert et al. · The FASEB Journal · 2006 · 222 citations
Docosahexaenoic Acid, Lipid Peroxidation, Cell Death +16
5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity
Raquel Horrillo, Ana González‐Périz, Marcos Martínez‐Clemente et al. · The Journal of Immunology · 2010 · 148 citations
Experimental Obesity, Immunology, Adipokines +20
The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activation
Anna Planagumà, Joan Clària, Rosa Miquel et al. · The FASEB Journal · 2005 · 134 citations
Ppargamma Expression, Immunology, Pathology +20
1–5 of 16